Metabolomic fingerprinting: challenges and opportunities.
暂无分享,去创建一个
[1] Jung-Wook Bang,et al. A metabolic entropy approach for measurements of systemic metabolic disruptions in patho-physiological States. , 2010, Journal of proteome research.
[2] R. Kaliszan,et al. Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques , 2010, Electrophoresis.
[3] F. Wright,et al. Use of Pharmaco‐Metabonomics for Early Prediction of Acetaminophen‐Induced Hepatotoxicity in Humans , 2010, Clinical pharmacology and therapeutics.
[4] Q. Zhan,et al. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer. , 2010, Journal of proteome research.
[5] Eytan Ruppin,et al. Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model , 2010, Bioinform..
[6] M. Aller,et al. A Review of metabolic staging in severely injured patients , 2010, Scandinavian journal of trauma, resuscitation and emergency medicine.
[7] Elaine Holmes,et al. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues , 2010, Nature Protocols.
[8] David S. Wishart,et al. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..
[9] G. Mingrone,et al. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype , 2010, International Journal of Obesity.
[10] J. Utzinger,et al. Integrated Cytokine and Metabolic Analysis of Pathological Responses to Parasite Exposure in Rodents , 2010, Journal of proteome research.
[11] Bin Wang,et al. Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. , 2009, Journal of proteome research.
[12] Manuel Desco,et al. A novel R-package graphic user interface for the analysis of metabonomic profiles , 2009, BMC Bioinformatics.
[13] H. Keun,et al. Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy , 2009, Clinical Cancer Research.
[14] Charles S Henry,et al. Review: Microfluidic applications in metabolomics and metabolic profiling. , 2009, Analytica chimica acta.
[15] Bowei Xi,et al. 1H NMR metabolomics study of age profiling in children , 2009, NMR in biomedicine.
[16] Jeremiah Stamler,et al. Large-scale human metabolic phenotyping and molecular epidemiological studies via 1H NMR spectroscopy of urine: investigation of borate preservation. , 2009, Analytical chemistry.
[17] David S. Wishart,et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..
[18] A. Darzi,et al. The gut microbiota as a target for improved surgical outcome and improved patient care. , 2009, Current pharmaceutical design.
[19] F. Jessen,et al. Association of SORL1 gene variants with Alzheimer's disease , 2009, Brain Research.
[20] Alexey V Antonov,et al. TICL – a web tool for network‐based interpretation of compound lists inferred by high‐throughput metabolomics , 2009, The FEBS journal.
[21] John T. Wei,et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.
[22] Jens Stoye,et al. MeltDB: a software platform for the analysis and integration of metabolomics experiment data , 2008, Bioinform..
[23] David S. Wishart,et al. MetaboMiner – semi-automated identification of metabolites from 2D NMR spectra of complex biofluids , 2008, BMC Bioinformatics.
[24] J. Lindon,et al. Systems biology: Metabonomics , 2008, Nature.
[25] Ara Darzi,et al. The human gut microbiome: Implications for future health care , 2008, Current gastroenterology reports.
[26] Ian D. Wilson,et al. Metabolic Phenotyping in Health and Disease , 2008, Cell.
[27] Ian J. Brown,et al. Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.
[28] Karsten Suhre,et al. MassTRIX: mass translator into pathways , 2008, Nucleic Acids Res..
[29] Xin Lu,et al. LC-MS-based metabonomics analysis. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] M. Elisaf,et al. Gender‐related and age‐related urinalysis of healthy subjects by NMR‐based metabonomics , 2008, NMR in biomedicine.
[31] Haifeng Lu,et al. Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.
[32] John L Markley,et al. Metabolite identification via the Madison Metabolomics Consortium Database , 2008, Nature Biotechnology.
[33] Charlotte Schubert,et al. Alterations in cerebral metabolomics and proteomic expression during sepsis. , 2007, Current neurovascular research.
[34] Royston Goodacre,et al. Metabolic fingerprinting as a diagnostic tool. , 2007, Pharmacogenomics.
[35] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[36] Lyle Burton,et al. Investigation of analytical variation in metabonomic analysis using liquid chromatography/mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.
[37] Russ Greiner,et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.
[38] Zheng Li,et al. A Three Stage Integrative Pathway Search (TIPS©) framework to identify toxicity relevant genes and pathways , 2007, BMC Bioinformatics.
[39] J. Nicholson,et al. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. , 2007, Analytical chemistry.
[40] R. Jirtle,et al. Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.
[41] Ian D Wilson,et al. Analytical strategies in metabonomics. , 2007, Journal of proteome research.
[42] Ronald S. Tjeerdema,et al. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics , 2007, Metabolomics.
[43] Joshua D. Knowles,et al. Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. , 2007, Analytical chemistry.
[44] Ying Zhang,et al. HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..
[45] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[46] M. Rantalainen,et al. OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification , 2006 .
[47] K. Alton,et al. Application of mass spectrometry for metabolite identification. , 2006, Current drug metabolism.
[48] Doris M Jacobs,et al. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. , 2006, Analytical biochemistry.
[49] A. Feinberg,et al. The emerging science of epigenomics. , 2006, Human molecular genetics.
[50] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[51] J. Griffin. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[52] I. Wilson,et al. Metabolic phenotyping of nude and normal (Alpk:ApfCD, C57BL10J) mice. , 2006, Journal of proteome research.
[53] Elaine Holmes,et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.
[54] I. Wilson,et al. A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.
[55] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[56] J. Lindon,et al. NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.
[57] I. Wilson,et al. Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.
[58] D. Gauguier,et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.
[59] J. Trygg,et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. , 2005, Analytical chemistry.
[60] Elaine Holmes,et al. The challenges of modeling mammalian biocomplexity , 2004, Nature Biotechnology.
[61] Philip W. Kuchel,et al. Metabonomics Based on NMR Spectroscopy , 2004 .
[62] D. Kell. Metabolomics and systems biology: making sense of the soup. , 2004, Current opinion in microbiology.
[63] Peter A. Jones,et al. Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.
[64] T. Ebbels,et al. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. , 2004, Chemical research in toxicology.
[65] Jeremy K Nicholson,et al. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. , 2004, Physiological genomics.
[66] Ralf J. O. Torgrip,et al. Peak alignment using reduced set mapping , 2003 .
[67] J. Griffin,et al. High‐resolution diffusion and relaxation‐edited magic angle spinning 1H NMR spectroscopy of intact liver tissue , 2003, Magnetic resonance in medicine.
[68] M. Fink,et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[69] I. Wilson,et al. Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.
[70] F. Guarner,et al. Gut flora in health and disease , 2003, The Lancet.
[71] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[72] I. Wilson,et al. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS‐DA , 2002, FEBS letters.
[73] T. Ebbels,et al. Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. , 2002, Chemical research in toxicology.
[74] J. Griffin,et al. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. , 2002, Analytical chemistry.
[75] L. Magnotti,et al. Influence of gut microflora on mesenteric lymph cytokine production in rats with hemorrhagic shock. , 2002, The Journal of trauma.
[76] Erik Johansson,et al. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic lesions using statistical batch processing of NMR data. , 2002, The Analyst.
[77] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[78] N. Reo. NMR-BASED METABOLOMICS , 2002, Drug and chemical toxicology.
[79] E Holmes,et al. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution (1)H NMR spectroscopy of urine and pattern recognition. , 2001, Analytical biochemistry.
[80] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[81] J. Griffin,et al. The biochemical profile of rat testicular tissue as measured by magic angle spinning 1H NMR spectroscopy , 2000, FEBS letters.
[82] John C. Lindon,et al. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids , 2000 .
[83] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[84] J. Macfie,et al. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity , 1999, Gut.
[85] I. J. Fraser,et al. A rapid and efficient approach to metabolite identification using nuclear magnetic resonance spectroscopy, liquid chromatography/mass spectrometry and liquid chromatography/nuclear magnetic resonance spectroscopy/sequential mass spectrometry , 1998 .
[86] E Holmes,et al. Development of a model for classification of toxin‐induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition , 1998, NMR in biomedicine.
[87] E Holmes,et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.
[88] C Zuppi,et al. 1H NMR spectra of normal urines: reference ranges of the major metabolites. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[89] J C Lindon,et al. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. , 1994, Molecular pharmacology.
[90] E Holmes,et al. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. , 1992, Molecular pharmacology.
[91] J. Nicholson,et al. Investigations into the biochemical effects of region-specific nephrotoxins. , 1989, Molecular pharmacology.
[92] Rachel Cavill,et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.
[93] Timothy M. D. Ebbels,et al. Genetic algorithms for simultaneous variable and sample selection in metabonomics , 2009, Bioinform..
[94] A. Zell,et al. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[95] Huanwen Chen,et al. Monitoring diet effects via biofluids and their implications for metabolomics studies. , 2007, Analytical chemistry.
[96] Kazuhisa Yoshiya,et al. Altered gut flora and environment in patients with severe SIRS. , 2006, The Journal of trauma.
[97] Xiaohui Fan,et al. Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.
[98] J. Griffin,et al. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. , 2004, Current drug metabolism.
[99] Elaine Holmes,et al. Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.
[100] Jeremy K. Nicholson,et al. Global systems biology, personalized medicine and molecular epidemiology , 2006, Molecular systems biology.
[101] P. Sajda,et al. Bioinformatics Applications Note Hires—a Tool for Comprehensive Assessment and Interpretation of Metabolomic Data , 2022 .